Exclusive from Whitehall. A source close to the Department of Health and Social Care confirms three separate Ebola vaccines are now in development. The UK is quietly positioning itself at the centre of the global response. This is not a drill. The outbreak in Equateur Province has the World Health Organisation spooked. Cases are rising. The border closures are starting. But here’s the thing Westminster doesn’t want you to know: the real fight is in the labs.
Two of the vaccine candidates are based on viral vector platforms. The third is a novel mRNA approach. Funding has been fast-tracked. The Treasury signed off on an £18 million package last night. No press release. No fanfare. Just a quiet transfer to the UK Vaccine Network. This is classic British soft power. We don’t boast. We just deliver.
The politics is delicate. The PM is facing a backbench revolt over aid cuts. Remember the 0.7% row? This is the perfect cover. A visible, humanitarian intervention that plays to the Tory internationalist wing. But the real game is about influence. The UK wants to be the go-to partner for Africa. The Chinese are already there. The French are sniffing around. This is a quiet tug of war.
One vaccine is being developed at Imperial College. Another at Oxford. The third is a collaboration between Public Health England and a private biotech firm. The names are being kept under wraps for now. Security concerns, they say. More likely, they don’t want a bidding war before phase one trials.
Polling shows the public is nervous. 62% support increased spending on pandemic preparedness. But only if it’s visible. The PM’s approval rating on health is underwater. This could be a lifeline. Or it could be another PR disaster if the vaccines fail.
Cabinet is split. The international development secretary wants to go big. The chancellor is worried about the bill. The health secretary is playing both sides. Classic Whitehall turf war. The real power lies with the chief scientific adviser. He’s the one pulling the strings.
Backbenchers are restless. The Covid Inquiry has everyone on edge. No one wants to be seen as slow. But the Treasury is watching every penny. The mood in the Lobby is cautious. This is a high-risk, high-reward play.
Meanwhile, the WHO is briefing that the outbreak could spread to major cities within weeks. Kinshasa is a tinderbox. The UK has already deployed a rapid response team. They’re in Mbandaka now. Setting up field laboratories. Training local staff. It’s textbook British diplomacy. Quiet. Effective. Understated.
The key question: can they scale? Manufacturing is the bottleneck. The UK has capacity at Porton Down. But it’s limited. The government is in talks with India. No deal yet.
This story is moving fast. I’ll have more when I get it. Keep an eye on the scientific journals. The data will leak first.
